Therapeutics Anti-Infective and Anti-Inflammatory Agents

Prevention of postoperative intestinal adhesions with combined promethazine and dexamethasone therapy: experimental and clinical studies

Replogle RL, Johnson R, Gross RE

Published April 1966 Annals of Surgery, 163(4), 580-588
DOI 10.1097/00000658-196604000-00011 PMID 5935011

RRM Academy Synopsis

Promethazine and dexamethasone reduced bowel adhesions in dogs

Promethazine plus dexamethasone left 8 out of 10 dogs free of bowel adhesions after deliberate injury. None of the 70 untreated dogs stayed free of adhesions. The 1966 report pairs this controlled animal experiment with a clinical series of 27 patients, 22 of them babies and young children.

Study at a glance, controlled animal experiment of 90 dogs: Promethazine and dexamethasone reduced bowel adhesions in dogs
Study at a glance, controlled animal experiment of 90 dogs: Promethazine and dexamethasone reduced bowel adhesions in dogs. Source: Replogle RL et al., 1966, PMID 5935011.

Key Findings

  • After a standardized scrubbing injury to the ileum in 90 dogs, 16 of 20 treated dogs had no adhesions and 4 had minimal adhesions. None had moderate to severe adhesions.
  • Among the 70 untreated dogs, none was free of adhesions: 7 had minimal adhesions and 63 had moderate to severe adhesions.
  • When existing adhesions were divided in dogs, 25 of 43 treated dogs had none, 14 had minimal and 4 had moderate to severe adhesions. Among 27 untreated dogs, 25 had dense adhesions.
  • Of 27 patients, 7 had obstruction from existing adhesions: 5 did well, 1 died with no adhesions found at autopsy, and 1 developed a fistula believed to result from questionable bowel viability.
  • An addendum reports 81 patients treated, from newborns to age 89, with very satisfactory results and no treatment-related complications except probable oversedation of one newborn.

Interpretation

This is a controlled animal experiment paired with a human case series. Dogs given a standardized bowel injury were treated with promethazine and dexamethasone or left untreated, then the abdomen was re-explored days to weeks later to grade adhesions. Reconnected bowel showed no leakage in 12 further treated dogs. The human series followed 27 treated patients, and an addendum covers 81 more patients from newborns to age 89. The authors call the results very encouraging and say further observations in humans are indicated.

RRM Context

Restorative reproductive medicine aims to return anatomy to normal function. Adhesions bind organs that should move freely. Preventing them belongs to the operation itself, alongside excision of disease. This 1966 report describes an early attempt to prevent bowel adhesions after abdominal surgery with drugs given before, during and after the operation.

Abstract

This study, combining experimental and clinical data, attempted to develop methods to prevent formation of adhesions in the highly susceptible infant undergoing abdominal surgery and to inhibit reformation of adhesions after surgical division of those which had appeared after some previous operation. Rats were treated with a combination of dexamethasone (Decadron) and promethazine (Phenergan). This series showed that the inflamma tory phase that follows trauma to intestinal serosa can be minimized and the organization of inflammatory exudate into fibrous adhesions can be delayed with this combination treatment (antihistamine plus adrenal cortex hormones). An addendum notes that so far 81 patients have been treated with the drug combination, and the results are characterized as very satisfactory, with no complications related to treatment. 2 points are emphasized: 1) since adhesion formation begins within minutes of peritoneal trauma, prevention requires a high level of drug saturation at the time of injury; and 2) large doses of drugs are required for maximum benefit. Experimentally, this study used 1 mg/kg of each drug, intramuscularly, 6-3 hours preoperatively, with dose repetetion via intraperitoneal saline as the abdomen is being closed for 2-36 hours postoperatively.

Topics

By this author

Related research

Therapeutics › Anti-Infective and Anti-Inflammatory Agents › Immune Modulating Agents
Robert L. Replogle, Randolph Johnson, Robert E. Gross
Bob Replogle, Rob Replogle, Bobby Replogle, R Replogle, R Johnson, Bob Gross, Rob Gross, Bobby Gross, R Gross
PMID 5935011 5935011 DOI 10.1097/00000658-196604000-00011 10.1097/00000658-196604000-00011 Replogle et al. 1966, Replogle 1966